RxDoctor Payments Data

Rebecca Ussery, PA

Physician Assistant · Dalton, GANPI 1063181956

Payments from drug & device makers

$2,807in general payments, 2019–2025

Across 163 payments — averaging $17.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$433
  • Pfizer$389
  • Lilly USA, LLC$289
  • AbbVie$217
  • AstraZeneca$152
  • Amgen$132
  • plus $1K from 26 others

What the payments were for

  • Food & beverage$2,807100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,807 in reported general payments places this provider in the 80th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$89,523
Medicare patients
329
Services billed
2,919

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide29$43,987
OzempicSemaglutide31$41,948
FarxigaDapagliflozin Propanediol24$32,340
EliquisApixaban33$27,790
MounjaroTirzepatide23$23,285
JanuviaSitagliptin Phosphate21$21,170
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$14,115
MyrbetriqMirabegron11$8,069
Pantoprazole Sodium127$1,411
Rosuvastatin Calcium111$1,374
Levothyroxine Sodium194$1,321
Azelastine Hcl46$1,031
Atorvastatin Calcium109$837
Lisinopril137$601
Sertraline Hcl70$508

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$289$67,27252 claims
Novo NordiskOzempic$433$41,94831 claims
AstraZenecaFarxiga$152$32,34024 claims
PfizerEliquis$389$27,79033 claims
MerckJanuvia$56$21,17021 claims
GSKTrelegy Ellipta$70$14,11522 claims
Astellas Pharma US IncMyrbetriq$96$8,06911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Dalton

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →